Rich Franco

Rich Franco is a seasoned professional currently serving as Head of Operations and Strategy at Aer Therapeutics, Inc., where responsibilities include leading regulatory, CMC, and corporate operations since May 2023. Additionally, Franco has held the position of Chief Regulatory Officer at Eiger BioPharmaceuticals since April 2016, overseeing development and regulatory activities for several key products, including Zokinvy (lonafarnib) and various projects related to lonafarnib HDV, Lambda Covid, Lambda HDV, and Avexitide PBH/CHI.